BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.

BMJ Mental Health, published by the esteemed BMJ PUBLISHING GROUP, is a pioneering open-access journal dedicated to advancing research and knowledge in the field of Psychiatry and Mental Health. Launched in 2023, this journal has rapidly established itself within the academic community, achieving a prestigious Q1 ranking and a ranking of #123 out of 567 in its category, placing it in the 78th percentile according to Scopus. With its base in the United Kingdom, the journal aims to foster impactful research through its commitment to accessibility, allowing professionals, researchers, and students alike to engage with high-quality content freely. The E-ISSN: 2755-9734 enables seamless digital access to cutting-edge studies, reviews, and perspectives that address the complexities of mental health, thereby paving the way for better practices and innovations in mental health care. Join a community of dedicated scholars and practitioners in reshaping the landscape of mental health research with BMJ Mental Health.

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.

Middle East Current Psychiatry (MECPsych), published by SpringerNature, is a prominent open-access journal dedicated to advancing the field of psychiatry and mental health in the Middle East and beyond. Since its establishment in 2011, MECPsych has aimed to disseminate high-quality research, reviews, and reports that capture recent developments in psychiatric science, clinical practice, and public health considerations in mental well-being. With an impact factor reflective of its growing influence and classified in the Q3 quartile for Psychiatry and Mental Health, the journal offers invaluable insights backed by rigorous peer review processes. Operating under an open access model since 2019, MECPsych ensures that its articles are freely accessible to a global readership, enhancing the visibility and application of research findings. As part of its ongoing commitment to enriching understanding in the field, MECPsych also encourages submissions that explore the unique cultural, societal, and economic factors influencing mental health across the region. This approach not only supports researchers, professionals, and students in their pursuit of knowledge but also fosters a collaborative dialogue among mental health stakeholders in the Middle East and around the world.

The JOURNAL OF CLINICAL PSYCHOLOGY, published by Wiley, has been a pivotal resource in the field of psychological research since its inception in 1945. With an impressive impact factor and classification within the Q1 category for both Arts and Humanities and Clinical Psychology, it ranks prominently at #54/552 in Arts and Humanities and #71/311 in Clinical Psychology according to Scopus, placing it in the top percentiles for both categories. The journal primarily serves as a platform for disseminating groundbreaking research, theoretical advancements, and practical applications pertinent to clinical psychology, making it indispensable for researchers, clinicians, and scholars dedicated to enhancing mental health practices. Although not an open-access journal, it provides critical insights and methodologies that are fundamental for professionals navigating the complexities of clinical psychology today. With a commitment to advancing understanding and treatment of psychological disorders, the journal continues to shape outcomes in mental health and therapeutic practices.

JOURNAL OF PSYCHOPHARMACOLOGY, published by SAGE Publications Ltd, is a leading peer-reviewed journal that explores the intricate dynamics of pharmacological interventions in mental health and psychiatry. With an ISSN of 0269-8811 and an E-ISSN of 1461-7285, this esteemed journal has established its reputation in the field since its inception in 1987, converging research excellence into 2024. Recognized as a Q1 journal in various categories including Medicine (miscellaneous), Pharmacology, and Psychiatry and Mental Health, it ranks impressively within the top percentile in Scopus, standing at #64 out of 567 in Psychiatry and Mental Health, and #31 out of 272 in Medical Pharmacology. The journal serves as a vital resource for researchers, professionals, and students, providing insightful articles that advance the understanding of psychopharmacological effects and innovations. Although it does not offer open access, the journal's extensive research and impactful findings make it essential reading for anyone engaged in the field. For those seeking to stay at the forefront of psychopharmacology, the JOURNAL OF PSYCHOPHARMACOLOGY is an invaluable asset.

Journal of Psychiatric Practice, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of psychiatry and mental health. With a focus on evidence-based clinical practice, the journal has been a respected resource since its inception, providing a platform for a wide range of articles, including original research, reviews, and case reports from 1997 to the present. As of 2023, it holds a Q3 ranking in Psychiatry and Mental Health, reflecting its influential role in the academic community. The Journal is aimed at researchers, mental health professionals, and students, promoting the dissemination of essential knowledge and innovative practices. Subscribers benefit from the latest findings and discussions in the field while contributing to the ongoing advancements in psychiatric care. Although not classified as open access, the journal ensures wide accessibility to its valuable content, further solidifying its commitment to the mental health discipline.

Indian Journal of Psychiatry (ISSN: 0019-5545, E-ISSN: 1998-3794) is a premier, peer-reviewed academic journal published by WOLTERS KLUWER MEDKNOW PUBLICATIONS. As a leading publication in the field of psychiatry and mental health since its establishment in 1970, the journal has significantly contributed to the advancement of psychiatric research and clinical practice in India and globally. With an impact factor reflecting its robust academic reputation, the journal is categorized under the Q3 quartile in its field for 2023 and ranks #228 out of 567 in the Scopus rankings. This Open Access journal has been providing cutting-edge research insights since 2007, ensuring that access to vital findings and innovative methodologies is available to a wide readership without restrictions. The Indian Journal of Psychiatry is dedicated to the dissemination of quality research, clinical studies, and reviews, aiming to enhance understanding and treatment of mental health disorders. It serves as an essential resource for researchers, practitioners, and students striving to improve mental health outcomes in diverse populations.

Current Psychiatry Reports, published by Springer, is a premier academic journal dedicated to the dissemination of cutting-edge research in the field of psychiatry and mental health. With a significant impact factor reflecting its esteemed position at Q1 in Psychiatry, this journal ranks an impressive #35 out of 567 in its category, placing it within the 93rd percentile of psychiatric publications as per Scopus metrics. Since its inception in 1996, it has provided a vital platform for clinicians, researchers, and students to explore and discuss contemporary psychiatric issues, advancements, and methodologies. While Current Psychiatry Reports is a subscription-based journal, its robust scholarly contributions are invaluable for practitioners and scholars looking to stay abreast of developments and empirical studies that shape the field. Based in the United States, at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, it remains an authoritative source for evidence-based insights that guide both research and clinical practice in mental health.